Psychotropics in pregnancy: safety and other considerations.
暂无分享,去创建一个
[1] G. Visser,et al. Selective serotonin reuptake inhibitors in pregnancy. , 2012, Current medicinal chemistry.
[2] Shae-Leigh C Vella,et al. Reason for clozapine cessation , 2012, Acta psychiatrica Scandinavica.
[3] D. Creedy,et al. Prevalence and factors associated with the development of antenatal and postnatal depression among Jordanian women. , 2011, Midwifery.
[4] T. Bärnighausen,et al. The prevalence and clinical presentation of antenatal depression in rural South Africa , 2011, Journal of affective disorders.
[5] R. Uher,et al. The contribution of prenatal and postnatal maternal anxiety and depression to child maladjustment , 2011, Depression and anxiety.
[6] S. Gentile. Suicidal mothers , 2011, Journal of injury & violence research.
[7] L. Altshuler,et al. A prospective, naturalistic, blinded study of early neurobehavioral outcomes for infants following prenatal antidepressant exposure. , 2011, The Journal of clinical psychiatry.
[8] M. Rotheram-Borus,et al. Depressed mood in pregnancy: Prevalence and correlates in two Cape Town peri-urban settlements , 2011, Reproductive health.
[9] A. Buist,et al. Developmental Outcomes of Children Exposed to Antidepressants in Pregnancy , 2011, The Australian and New Zealand journal of psychiatry.
[10] L. Lazzeroni,et al. Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development , 2011, Psychopharmacology.
[11] R. Stewart,et al. Social support and antenatal depression in extended and nuclear family environments in Turkey: a cross-sectional survey , 2011, BMC psychiatry.
[12] I. Petersen,et al. Pregnancy as a major determinant for discontinuation of antidepressants: an analysis of data from The Health Improvement Network. , 2011, The Journal of clinical psychiatry.
[13] S. Shah,et al. Prevalence of antenatal depression: comparison between Pakistani and Canadian women. , 2011, JPMA. The Journal of the Pakistan Medical Association.
[14] D. Cohen,et al. Depression during pregnancy: is the developmental impact earlier in boys? A prospective case-control study. , 2011, The Journal of clinical psychiatry.
[15] M. Gissler,et al. Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries , 2011, BMJ : British Medical Journal.
[16] A. Buist,et al. Mood Stabilizers in Pregnancy: A Systematic Review , 2010, The Australian and New Zealand journal of psychiatry.
[17] Satish Iyengar,et al. A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. , 2010, Archives of general psychiatry.
[18] A. Bérard,et al. Use of antidepressants during pregnancy and the risk of spontaneous abortion , 2010, Canadian Medical Association Journal.
[19] S. Gentile. Neurodevelopmental effects of prenatal exposure to psychotropic medications , 2010, Depression and anxiety.
[20] A. Çeti̇n,et al. Prevalence and Correlates of Depression in Pregnancy Among Turkish Women , 2010, Maternal and Child Health Journal.
[21] R. Pinheiro,et al. Depression during pregnancy in the Brazilian public health care system. , 2010, Revista brasileira de psiquiatria.
[22] A. Buist,et al. Neonatal Growth Outcomes at Birth and one Month Postpartum Following In Utero Exposure to Antidepressant Medication , 2010, The Australian and New Zealand journal of psychiatry.
[23] T. Vik,et al. Maternal postnatal depression and child growth: a European cohort study , 2010, BMC pediatrics.
[24] Herng‐Ching Lin,et al. Maternal bipolar disorder increased low birthweight and preterm births: a nationwide population-based study. , 2010, Journal of affective disorders.
[25] Herng‐Ching Lin,et al. Maternal schizophrenia and pregnancy outcome: Does the use of antipsychotics make a difference? , 2010, Schizophrenia Research.
[26] B. Källén,et al. Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data , 2010, Psychological Medicine.
[27] G. Koren,et al. Adverse effects of antidepressant use in pregnancy: an evaluation of fetal growth and preterm birth , 2010, Depression and anxiety.
[28] S. Hernández-Díaz,et al. Antidepressant Use During Pregnancy and the Risk of Preterm Delivery and Fetal Growth Restriction , 2009, Journal of clinical psychopharmacology.
[29] H. Salihu,et al. Risk factors for major antenatal depression among low-income African American women. , 2009, Journal of women's health.
[30] V. Pop,et al. Prenatal maternal emotional complaints are associated with cortisol responses in toddler and preschool aged girls. , 2009, Developmental psychobiology.
[31] T. Henriksen,et al. Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes. , 2009, Archives of pediatrics & adolescent medicine.
[32] J. Olsen,et al. Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study , 2009, BMJ : British Medical Journal.
[33] C. Monk,et al. Impact of maternal stress, depression and anxiety on fetal neurobehavioral development. , 2009, Clinical obstetrics and gynecology.
[34] J. Lum,et al. Serotonin Discontinuation Syndrome Following in Utero Exposure to Antidepressant Medication: Prospective Controlled Study , 2009, The Australian and New Zealand journal of psychiatry.
[35] G. Hofmeyr,et al. Atypical antipsychotic (clozapine) self‐poisoning in late pregnancy presenting with absent fetal heart rate variability without acidosis and delayed peristalsis in the newborn baby: A case report , 2009, The Australian & New Zealand journal of obstetrics & gynaecology.
[36] Carla M Bann,et al. Prevalence of Anxiety, Depression and Associated Factors Among Pregnant Women of Hyderabad, Pakistan , 2009, The International journal of social psychiatry.
[37] E. Tronick,et al. Infants of depressed mothers. , 2009, Harvard review of psychiatry.
[38] G. Koren,et al. Maternal Use of Venlafaxine Near Term: Correlation Between Neonatal Effects and Plasma Concentrations , 2009, Therapeutic drug monitoring.
[39] J. Oosthuizen,et al. Antenatal depression and suicidal ideation among rural Bangladeshi women: a community-based study , 2009, Archives of Women's Mental Health.
[40] Lisa M Bodnar,et al. Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes. , 2009, The American journal of psychiatry.
[41] A. Pottinger,et al. Detecting depression during pregnancy and associated lifestyle practices and concerns among women in a hospital-based obstetric clinic in Jamaica. , 2009, General hospital psychiatry.
[42] T. Einarson,et al. Incidence of Major Malformations in Infants following Antidepressant Exposure in Pregnancy: Results of a Large Prospective Cohort Study , 2009, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[43] R. McIntyre,et al. Teratogenesis associated with antibipolar agents , 2009, Advances in therapy.
[44] David J. Loren,et al. Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn , 2009, Pharmacoepidemiology and drug safety.
[45] S. Gentile,et al. Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of fetal major malformations: focus on paroxetine. , 2009, The Journal of clinical psychiatry.
[46] T. Mendelson,et al. Risks and predictors of readmission for a mental disorder during the postpartum period. , 2009, Archives of general psychiatry.
[47] A. Einarson,et al. Smoking in pregnancy and lactation: a review of risks and cessation strategies , 2009, European Journal of Clinical Pharmacology.
[48] Christina L. Wichman. Atypical antipsychotic use in pregnancy: a retrospective review , 2009, Archives of Women's Mental Health.
[49] K. Matthews,et al. Trajectories of maternal depressive symptoms over her child's life span: Relation to adrenocortical, cardiovascular, and emotional functioning in children , 2009, Development and Psychopathology.
[50] S. Gentile. Pregnancy Exposure to Serotonin Reuptake Inhibitors and the Risk of Spontaneous Abortions , 2008, CNS Spectrums.
[51] A. Stein,et al. The influence of maternal depression, caregiving, and socioeconomic status in the post-natal year on children's language development. , 2008, Child: care, health and development.
[52] Y. Béjot,et al. Central pontine and extra-pontine myelinolysis: A complication of lithium toxicity in a pregnant woman , 2008, Clinical Neurology and Neurosurgery.
[53] B. Källén,et al. Maternal use of selective serotonin re‐uptake inhibitors and persistent pulmonary hypertension of the newborn , 2008, Pharmacoepidemiology and drug safety.
[54] R. Shakya,et al. Depression during pregnancy in a tertiary care center of eastern Nepal. , 2008, JNMA; journal of the Nepal Medical Association.
[55] J. Heron,et al. The impact of maternal depression in pregnancy on early child development , 2008, BJOG : an international journal of obstetrics and gynaecology.
[56] B. Källén,et al. Maternal Use of Antipsychotics in Early Pregnancy and Delivery Outcome , 2008, Journal of clinical psychopharmacology.
[57] T. Einarson,et al. Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy. , 2008, The American journal of psychiatry.
[58] P. Mcelhatton,et al. Birth weight of infants after maternal exposure to typical and atypical antipsychotics: Prospective comparison study , 2008, British Journal of Psychiatry.
[59] A. Bérard,et al. Duration of antidepressant use during pregnancy and risk of major congenital malformations , 2008, British Journal of Psychiatry.
[60] J. Milgrom,et al. Risk factors for antenatal depression, postnatal depression and parenting stress , 2008, BMC psychiatry.
[61] G. Dekker,et al. Antenatal Psychosocial Risk Factors and Depression Among Women Living in Socioeconomically Disadvantaged Suburbs in Adelaide, South Australia , 2008, The Australian and New Zealand journal of psychiatry.
[62] Ş. Turan,et al. Case Report: Clozapine use in two women with schizophrenia during pregnancy , 2008, Journal of psychopharmacology.
[63] K. Hollins. Consequences of antenatal mental health problems for child health and development , 2007, Current opinion in obstetrics & gynecology.
[64] R. Baldessarini,et al. Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. , 2007, The American journal of psychiatry.
[65] V. Grech,et al. Antenatal psychiatric morbidity in Maltese women. , 2007, General hospital psychiatry.
[66] R. Platt,et al. Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy , 2007, Pharmacoepidemiology and drug safety.
[67] M. Bonati,et al. Neonatal outcome following pregnancy exposure to antidepressants: a prospective controlled cohort study , 2007, BJOG : an international journal of obstetrics and gynaecology.
[68] M. Kłyś,et al. Neonatal death following clozapine self-poisoning in late pregnancy: an unusual case report. , 2007, Forensic science international.
[69] J. Hennen,et al. Birth outcomes following prenatal exposure to antidepressants. , 2007, The Journal of clinical psychiatry.
[70] T. Einarson,et al. Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors. , 2007, Clinical therapeutics.
[71] Y. Lau,et al. Correlates of depressive symptomatology during the second trimester of pregnancy among Hong Kong Chinese. , 2007, Social science & medicine.
[72] D. Mendhekar. Possible delayed speech acquisition with clozapine therapy during pregnancy and lactation. , 2007, The Journal of neuropsychiatry and clinical neurosciences.
[73] V. Glover,et al. Antenatal maternal stress and long-term effects on child neurodevelopment: how and why? , 2007, Journal of child psychology and psychiatry, and allied disciplines.
[74] J. Dieter,et al. Maternal Depression and Psychotropic Medication Effects on the Human Fetus , 2006, Annals of the New York Academy of Sciences.
[75] Genine Thormahlen. Paroxetine Use During Pregnancy: Is it Safe? , 2006, The Annals of pharmacotherapy.
[76] T. Einarson,et al. Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes. , 2006, The Journal of clinical psychiatry.
[77] T. Furukawa,et al. Multicentre prospective study of perinatal depression in Japan: incidence and correlates of antenatal and postnatal depression , 2006, Archives of Women's Mental Health.
[78] S. Hernández-Díaz,et al. Selective Serotonin-Reuptake Inhibitors and Risk of Persistent Pulmonary Hypertension of the Newborn , 2006, The New England journal of medicine.
[79] K. Lohr,et al. Perinatal Depression: A Systematic Review of Prevalence and Incidence , 2005, Obstetrics and gynecology.
[80] D. Newport,et al. Lithium placental passage and obstetrical outcome: implications for clinical management during late pregnancy. , 2005, The American journal of psychiatry.
[81] P. Merlob,et al. Prolonged QT interval in an infant of a fluoxetine treated mother , 2005, Archives of Disease in Childhood.
[82] T. Einarson,et al. Antidepressant Use during Pregnancy and the Rates of Spontaneous Abortions: A Meta-Analysis , 2005, The Annals of pharmacotherapy.
[83] G. Koren,et al. Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study. , 2005, The Journal of clinical psychiatry.
[84] M. Clementi,et al. Safety of haloperidol and penfluridol in pregnancy: a multicenter, prospective, controlled study. , 2005, The Journal of clinical psychiatry.
[85] Andrew Bate,et al. Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis , 2005, The Lancet.
[86] C. Kozma. Neonatal toxicity and transient neurodevelopmental deficits following prenatal exposure to lithium: Another clinical report and a review of the literature , 2005, American journal of medical genetics. Part A.
[87] M. Unsal,et al. Newer antidepressants in pregnancy: prospective outcome of a case series. , 2004, Reproductive toxicology.
[88] D. Sahota,et al. A prevalence study of antenatal depression among Chinese women. , 2004, Journal of affective disorders.
[89] S. Gentile. Clinical Utilization of Atypical Antipsychotics in Pregnancy and Lactation , 2004, The Annals of pharmacotherapy.
[90] K. Abel,et al. Antipsychotic drugs for non-affective psychosis during pregnancy and postpartum. , 2004, The Cochrane database of systematic reviews.
[91] B. Källén. Neonate characteristics after maternal use of antidepressants in late pregnancy. , 2004, Archives of pediatrics & adolescent medicine.
[92] D. Stewart,et al. The effect of postpartum depression on child cognitive development and behavior: A review and critical analysis of the literature , 2003, Archives of Women’s Mental Health.
[93] H. Hoyme,et al. Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. , 2003, The Journal of pediatrics.
[94] P. Lalonde,et al. Clozapine et grossesse , 2003 .
[95] R. Davis,et al. Outcomes of prenatal antidepressant exposure. , 2002, The American journal of psychiatry.
[96] S. Misri,et al. Antipsychotic Medication during Pregnancy and Lactation in Women with Schizophrenia: Evaluating the Risk , 2002, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[97] Y. Yogev,et al. Maternal clozapine treatment and decreased fetal heart rate variability , 2002, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[98] D. Stewart,et al. Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. , 2002, The American journal of psychiatry.
[99] K. Cunningham,et al. Case report and review of the perinatal implications of maternal lithium use. , 2002, American journal of obstetrics and gynecology.
[100] G. Koren,et al. Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study. , 2001, The American journal of psychiatry.
[101] N. Craddock,et al. Familiality of the puerperal trigger in bipolar disorder: results of a family study. , 2001, The American journal of psychiatry.
[102] C. Katona,et al. Long-term outcome of severe puerperal psychiatric illness: a 23 year follow-up study , 2000, Psychological Medicine.
[103] R. Baldessarini,et al. Risk of Recurrence of Bipolar Disorder in Pregnant and Nonpregnant Women After Discontinuing Lithium Maintenance , 2000 .
[104] M. Fung,et al. Olanzapine-exposed pregnancies and lactation: early experience. , 2000, Journal of clinical psychopharmacology.
[105] G. Koren,et al. Safety of fluoxetine during the first trimester of pregnancy: a meta-analytical review of epidemiological studies , 2000, Psychological Medicine.
[106] R. Dickson,et al. Pregnancy of a patient treated with clozapine. , 1998, Psychiatric services.
[107] R. Baker,et al. Gastroesophageal reflux as a possible result of clozapine treatment. , 1998, The Journal of clinical psychiatry.
[108] C T Beck,et al. The effects of postpartum depression on child development: a meta-analysis. , 1998, Archives of psychiatric nursing.
[109] S. C. Stoner,et al. Clozapine use in two full-term pregnancies. , 1997, The Journal of clinical psychiatry.
[110] K. Jones,et al. Birth outcomes in pregnant women taking fluoxetine. , 1996, New England Journal of Medicine.
[111] T. Tényi,et al. [Use of clozapine during pregnancy]. , 1994, Orvosi hetilap.
[112] J. Jefferson,et al. A reevaluation of risk of in utero exposure to lithium. , 1994, JAMA.
[113] J. Kane. Clinical Efficacy of Clozapine in Treatment-Refractory Schizophrenia: An Overview , 1992, British Journal of Psychiatry.
[114] M. Lovejoy. Maternal depression: Effects on social cognition and behavior in parent-child interactions , 1991, Journal of abnormal child psychology.
[115] D. Gath,et al. The Relationship between Post-natal Depression and Mother–Child Interaction , 1991, British Journal of Psychiatry.
[116] B. Bettes,et al. Maternal depression and motherese: temporal and intonational features. , 1988, Child development.
[117] M. O’Hara,et al. The effects of maternal mood on mother-infant interaction , 1987, Journal of abnormal child psychology.
[118] T Sherman,et al. Speech patterning of natural discourse of well and depressed mothers and their young children. , 1986, Child development.
[119] 廣中 昌恵. Maternal mental disorders and pregnancy outcomes : a clinical study in a Japanese population , 2012 .
[120] S. Gentile,et al. Prenatal exposure to antidepressant medications and neurodevelopmental outcomes: a systematic review. , 2011, Journal of affective disorders.
[121] E. Simpson,et al. Infant serotonin transporter (SLC6A4) promoter genotype is associated with adverse neonatal outcomes after prenatal exposure to serotonin reuptake inhibitor medications , 2008, Molecular Psychiatry.
[122] A. Ornoy,et al. Is lithium a real teratogen? What can we conclude from the prospective versus retrospective studies? A review. , 2008, The Israel journal of psychiatry and related sciences.
[123] P. Sparén,et al. Incidence of hospitalization for postpartum psychotic and bipolar episodes in women with and without prior prepregnancy or prenatal psychiatric hospitalizations. , 2007, Archives of general psychiatry.
[124] P. Reebye,et al. Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancy. , 2007, Archives of pediatrics & adolescent medicine.
[125] L. Russo,et al. Evaluating the Postmarketing Experience of Risperidone Use During Pregnancy , 2007, Drug safety.
[126] A. Adewuya,et al. Prevalence and correlates of depression in late pregnancy among Nigerian women , 2007, Depression and anxiety.
[127] S. Zubrick,et al. Pregnancy, delivery, and neonatal complications in a population cohort of women with schizophrenia and major affective disorders. , 2005, The American journal of psychiatry.
[128] P. Lalonde,et al. [Clozapine and pregnancy]. , 2003, L'Encephale.
[129] S. Shima,et al. Clinical and psychosocial correlates of antenatal depression: a review. , 1996, Psychotherapy and psychosomatics.